baber/WOPTO huggingface dataset:
Patent AU-3028697-A (AU)
Title: Permanent way component and process for its production
Inventor: KAIS ALFRED
IPC: E01B7/00
Filed: 1997-05-22
Abstract: The invention relates to a permanent way component, especially a points component like a nose (14), consisting of sections (22, 24) of different materials to be joined together, in which the sections are subjected to a joint heat treatment after being joined. In order to produce a permanent way component with great tenacity and elastic limit it is proposed that, looked at in the longitudinal direction of the rail, the track component exhibit a layer structure in such a way that a head section (24) on which a rail vehicle can run directly is bonded to a base section (22), where said head section consists of a high-tensile steel, where the bonded sections are heat-treated together in such a way that the head section has an ultimate tensile strength RM2 of between 1,700 and 2,200 N/mm<2> and/or an elastic limit RE2 of between 1,600 and 1,800 N/mm<2>.
Patent AU-3371599-A (AU)
Title: Production of reduced gas-permeable polyalkylene terephthalate films by strain induced crystallization
Inventor: FREUNDLICH RICHARD
IPC: B29C48/32
Filed: 1999-03-30
Abstract: PET with low gas permeability and good mechanical properties is produced utilizing strain-induced crystallization. This strain-induced crystallization process is utilized to produce PET films and sheets, among other products.
Patent AU-3557095-A (AU)
Title: Injection means
Inventor: WHISSON MAXWELL EDMUND DR
IPC: A61M5/178
Filed: 1995-09-14
Abstract: PCT No. PCT/AU95/00604 Sec. 371 Date Mar. 13, 1997 Sec. 102(e) Date Mar. 13, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/08283 PCT Pub. Date Mar. 21, 1996An injection device comprising a hollow body (11) having a forward end (12) and a rearward end (13), the forward end (12) slidably receiving a hollow needle (15), the body (11) providing a chamber (A) between its forward end (12) and its rearward end (13), the chamber being defined between a plug (17) and a stop (18), the plug (17) being sealingly and slidably received within the body (11) adjacent the forward end (12), the stop (18) being slidably and sealingly received within the body (11) rearward of the plug (17) wherein a greater degree of effort must be applied to the stop (18) than to the plug (17) to effect slidable movement within the body, the rearward end (13) of the body having a portion (14) in which the stop (18) is not sealingly received within the body, a drive element (19) connected at one end to the plug (17) and slidingly and sealingly received through the stop (18) to extend from the rearward end (13) of the body (11), a manipulation member (20) provided on the other end of the drive element (19), the hollow interior of said needle (15) being connected to the chamber (A) through a flexible passageway (21) extending between the inner end of the needle (15) and the plug (17), the needle (15) being connected to the plug (17).
Patent AU-3565097-A (AU)
Title: Method and device for destruction of objects
Inventor: LINDSKOG KJELL
IPC: E05G1/14
Filed: 1997-07-06
Abstract: Method and device for destruction of objects stored in an alarm-protected security container. There is used a destructive agent which is distributed over the object or objects when the alarm is triggered, so as to mark and/or destroy the object/objects. There is also used a destructive device which includes an explosive agent that acts at least partially on the object/objects when the alarm is triggered. The device includes a channel whose opening faces towards the object/objects. The destructive agent is encapsulated in the channel and the explosive agent is disposed adjacent the channel. The channel has a generally U-shaped cross section and includes end-walls.
Patent AU-3704184-A (AU)
Title: Fermentation processes and their products
Inventor: MOLZAHN STUART WILLIAM
IPC: C12N15/81
Filed: 1984-12-21
Abstract: The invention provides a process for the production of ethanol and a protein or peptide which is heterologous to yeast which comprises fermenting an aqueous sugar-containing medium with an industrial yeast strain which has been genetically modified to be capable of expressing a heterologous protein or peptide, recovering the ethanol so-formed, and obtaining the said heterologous protein or peptide from the fermentation products. The process may be applied to the industrial production of alcoholic beverages such as beer or distilled alcohol. The yeast inevitably obtained as a by-product in the process has improved value because of the heterologous protein or peptide which it contains and provides a source of the latter. Heterologous protein and peptides which may be produced by the new process include enzymes such as beta-lactamase, beta-glucanase and beta-galactosidase and proteins of therapeutic value such as human serum albumen.
Patent AU-3745795-A (AU)
Title: Use of CCK-B receptor antagonists for the treatment of sleepdisorders
Inventor: RATTI EMILIANGELO
IPC: A61P25/20
Filed: 1995-10-12
Abstract: The use of CCK-B antagonists for the treatment of sleep disorders.
Patent AU-3810489-A (AU)
Title: Process for the preparation of s-cyanohydrins
Inventor: KULA MARIA-REGINA
IPC: C12P13/00
Filed: 1989-07-13
Abstract: The preparation of (S)-cyanohydrins by reaction of the corresponding oxo compounds with hydrocyanic acid can be achieved enzymatically with the aid of oxynitrilase (4.1.2.11) from Sorghum bicolor. This is preferably carried out in aqueous medium at pH values below 6.0, in particular below 4.5, in order to suppress competing chemical reactions and racemisations. The reaction temperatures are, in particular, between -5 DEG C and +50 DEG C. Of particular interest is the reaction of aromatic aldehydes, specifically benzaldehyde and its derivatives, and the generation of aldononitriles by reaction of aldoses, especially of sugars with 3 to 9 carbon atoms, with hydrocyanic acid.
Patent AU-3855085-A (AU)
Title: Production of protective layer or a relief image
Inventor: ZWEIFEL HANS
IPC: C07F7/10
Filed: 1985-02-08
Abstract: A process for the production of a protective layer or a relief image on a substrate, wherein a radiation-sensitive layer, consisting of a solid film-forming epoxy resin containing a photoinitiator, which can be activated by radiation, for the polyaddition reaction, is transferred from a support to a substrate, then exposed directly or under a photomask and hardened by the action of heat, after which, if appropriate, the unexposed parts are developed with a solvent. The process is suitable, for example, for the production of printed circuits, solder resist masks and offset printing plates.
Patent AU-3896199-A (AU)
Title: Methods and compositions for making fermented cereal products
Inventor: MEGEED MOHAMED EID A
IPC: A23L7/10
Filed: 1999-05-10
Abstract: The extent of fermentation of a food product by a microorganism can be controlled by using a selected quantity of a nutrient for which the microorganism is auxotrophic. For example, an improved sourdough bread product was produced using a bread dough made with a starter that included a Lactobacillus fermentum strain that is auxotrophic for methionine and a quantity of whey, a source of methionine, that was selected to stop fermentation when the bread dough reached a desired acidity level.
Patent AU-4136301-A (AU)
Title: Apparatus including eddy current braking system
Inventor: PRIBONIC EDWARD M
IPC: B60L7/28
Filed: 2000-11-17
Abstract: Eddy current braking apparatus includes a linear array of spaced apart permanent magnets arranged for defining a slot therebetween. A diamagnetic or non-magnetic fin is disposed and sized for movement through the slot. A pivotal linkage enables the magnets to move with respect to the fin from a spaced apart first position to a second position in which the fin passes through the slot. A control mechanism selectively moves the magnets between the first and second positions.
Patent AU-4236889-A (AU)
Title: Imidazoline derivative and preparation thereof
Inventor: MATSUMOTO KAZUO
IPC: A61P37/00
Filed: 1989-09-29
Abstract: Imidazoline derivative of the formula: <CHEM> wherein R is a halogenophenyl group or a pyridyl group and X<1> and X<2> are a hydrogen atom or a lower alkoxy group, or a pharmaceutically acceptable salt thereof, which is useful as an immunomodulator and as an agent for the treatment and/or prophylaxis of rheumathoid arthritis, multiple sclerosis, systemic lupus erythemathodes, rheumatic fever and the like, a process for the preparation thereof, and a pharmaceutical composition containing said compound as an active ingredient.
Patent AU-4266993-A (AU)
Title: Trunking and a venting arrangement for fire protection structure
Inventor: HACLIN GRAHAM JOHN
IPC: A62C2/06
Filed: 1993-04-27
Abstract: Cable trunking (10) lined with fire resistant thermal insulating material (13, 14). The trunking (10) has a panel (12) which is removable to provide access to the interior. The panel (12) has a channel section, the flanges (12A) of which form a gas-tight seal with the rest (11) of the casing. A normally-open vent arrangement (24-26) allows heat generated by the cables (16-18, 21-22) during normal operation to be dissipated. Each vent (26) is formed in a strip (24) of highly intumescent material which fills the interior of a top-hat section housing (25). In the event of a fire outside the trunking (10), the intumescent material within the housing (25) expands to form a rigid carbon plug which closes the respective vent (26).
Patent AU-4389593-A (AU)
Title: Novel cytokine that binds cd30
Inventor: GOODWIN RAYMOND G
IPC: C07K16/00
Filed: 1993-05-25
Abstract: There is disclosed a polypeptide (CD30-L) and DNA sequences, vectors and transformed host cells useful in providing CD30-L polypeptides. The CD30-L polypeptide binds to the receptor known as CD30, which is expressed on a number of cell types, among which are Hodgkin's Disease tumor cells, large cell anaplastic lymphoma cells, adult T-cell leukemia (T-ALL) cells, and a number of other malignant cell types. CD30-L polypeptides find use as carriers for delivering diagnostic and cytotoxic agents to cells expressing the CD30 receptor.
Patent AU-4395293-A (AU)
Title: Method for scanning photodiodes
Inventor: HAUGEN DOUGLAS G
IPC: G02B26/02
Filed: 1993-05-27
Abstract: A method for electronically scanning a photodiode array that is sequentially illuminated by individual light beams by way of a shutter mechanism that has opening and closing transition times during which each light beam is only partially projected onto the array. An integrating light projected on the respective photodiodes of the photodiode array by each light beam over a predetermined period of time beginning after the opening transition time when the shutter mechanism is fully open and ending prior to initiation of the closing transition time while the shutter mechanism is still fully open and producing electrical signals corresponding to the light integrated by the respective photodiodes over the predetermined period of time and storing the electrical signals for subsequent use.
Patent AU-4422797-A (AU)
Title: Methods and compositions for generating angiostatin
Inventor: SOFF GERALD
IPC: C12N5/077
Filed: 1997-09-18
Abstract: The invention provides methods of generating angiostatin in  vitro  comprising contacting plasminogen with a plasminogen activator and a sulfhydryl donor or contacting plasmin with a sulfhydryl donor. The invention also provides a method of treating angiogenic diseases by administering to an animal suffering from such a disease a sulfhydryl donor and, optionally, a plasminogen activator, plasminogen or plasmin. The invention further comprises a composition for generating angiostatin comprising a sulfhydryl donor and a plasminogen activator. The invention also provides a container holding a sulfhydryl donor and/or a plasminogen activator, said container having a label thereon instructing administration of the sulfhydryl donor and/or plasminogen activator to an animal suffering from an angiogenic disease. The invention further provides plasminogen fragments-whose N-terminal amino acid is the same as that of plasmin and whose C-terminal amino acid is located in kringle 5 and which inhibit angiogenesis, antibodies which bind selectively to these fragments, methods and kits for using the antibodies, methods and materials for making the fragments by recombinant DNA techniques, and a method of treating an angiogenic disease comprising administering an effective amount of one of the fragments. Finally, the invention provides a method of treating an angiogenic disease comprising administering a transgene coding for one of the fragments.
Patent AU-4529696-A (AU)
Title: Self-centering valvulotome
Inventor: LEMAITRE GEORGE D
IPC: A61B17/00
Filed: 1995-12-27
Abstract: Self-centering valvulotome (V) having a flexible cable (1) partly and slidably disposed within a protective sheath (2), a cutting unit (4), having at least three radially mounted, retractable cutting blades, attached to the cable at its distal end, and a dual-purpose control mechanism attached to the cable at its proximal end. Each retractable cutting blade comprises a free-floating cutting head and a flat spring section, which biases the cutting head against the venous wall. The control mechanism comprises a T-valve segment disposed partly within the proximal end of the protective sheath. A pull handle affixed to the proximal end of the cable can engage the T-valve such that a fluid-tight seal is created, thereby allowing the introduction of a diagnostic or therapeutic fluid to the protective sheath via an access port in the valve.
Patent AU-4653685-A (AU)
Title: Remotely controlled firing of ignition elements
Inventor: BIRSE ALAN D
IPC: F42D1/04
Filed: 1985-08-22
Abstract: Low level remotely generated control signals are amplified at a local ignition site using a local power source and the amplified control signals are used to charge a local energy storage device. Thereafter firing control signals (e.g., controlled duration suppressions of the remotely generated control signals) are detected and used to control discharge of the thus stored energy through an electrical ignition device.
Patent AU-4668593-A (AU)
Title: Thrombin receptor antagonists
Inventor: SCARBOROUGH ROBERT M JR
IPC: A61P9/10
Filed: 1993-07-08
Abstract: Peptide derivatives serving as thrombin receptor antagonists are disclosed, which bear specificity for the cellular thrombin receptor without interfering with the catalytic activities of thrombin. The derivatives generally have the formula    <IMAGE>kylamide linkages, or isosteric replacements of such linkages; R2 is either a neutral amino acid side chain or a hydrophobic radical; R4 is hydrophobic radical; R5 is CO, CH2 or SO; X is either of the formula:   <IMAGE>   in which R6 and R7 are H, alkyl, cycloalkylalkyl, alkoxyalkyl, alkylthioalkyl or arylalkyl, and R8 is a hydrophobic radical, or a hydrophobic residue; Y is alkoxy, hydroxy, amino, alkylamino, dialkylamino, in which any of the alkyl groups may be substituted with a basic moiety; Z is an amino acid or peptide residue; and m is zero or one.
Patent AU-4773399-A (AU)
Title: Method for producing water-insoluble alpha-1,4-glucan
Inventor: QUANZ MARTIN
IPC: C12R1/36
Filed: 1999-06-17
Abstract: An in-vitro method for producing water-insoluble alpha-1,4-glucan is described, wherein saccharose is reacted in a buffer-free system using an amylosaccharase.
Patent AU-4838490-A (AU)
Title: Triple stranded nucleic acid and methods of use
Inventor: HOGAN MICHAEL EDWARD
IPC: C12Q1/6839
Filed: 1989-12-20
Abstract: A method for making synthetic oligonucleotides which bind to target sequences in a duplex DNA forming colinear triplexes by binding to the major groove. The method includes scanning genomic duplex DNA and identifying nucleotide target sequences of greater than about 20 nucleotides having either about at least 65% purine bases or about at least 65% pyrimidine bases; and synthesizing synthetic oligonucleotides complementary to identified target sequences. The synthetic oligonucleotides have a G when the complementary location in the DNA duplex has a GC base pair and have a T when he complementary location in the DNA duplex has an AT base pair. The synthetic oligonucleotides are oriented 5 min  to 3 min  and bind parallel or 3 min  to 5 min  and bind anti-parallel to the about at least 65% purine strand. Also described are synthetic oligonucleotides made by the above methods. The oligonucleotides can be altered by modifying and/or changing the bases, adding linkers and modifying groups to the 5 min and/or 3 min  termini, and changing the backbone. These synthetic oligonucleotides bind to duplex DNA to form triplexes. This process alters the functioning of the genes which are bound. This process can be used to inhibit cell growth, alter protein ratios, treat diseases including cancer and permanently alter the DNA.
Patent AU-4872893-A (AU)
Title: Antithrombin III preparation
Inventor: AOYAMA TOSHINOBU
IPC: A61K47/26
Filed: 1993-10-01
Abstract: An antithrombin III is described comprising a lyophilized powder of antithrombin III and a polyoxyethylene glycol sorbitan alkyl ester as well as a kit composed of a container wherein a lyophilized powder of antithrombin III is placed and a solvent for the said powder characterized in that a polyoxyethylene glycol sorbitan alkyl ester is added to either or both of the said powder and the said solvent. That preparation has a high solubility in water by retaining its activity.
Patent AU-4972685-A (AU)
Title: An improved method and composition
Inventor: THULIN ROBERT RAYMOND
IPC: A21D13/08
Filed: 1985-11-07
Abstract: Cookies having an extended shelf-stable soft or chewy texture throughout the cookie are prepared by coextruding an inner adherent cookie dough bakeable to a soft or chewy texture and an outer non-adherent cookie dough bakeable to a soft or chewy texture. The inner dough comprises a liquid humectant in an amount sufficient to impart a shelf-stable soft or chewy texture to the baked outer cookie dough in excess of that attainable by baking the outer dough alone to a shelf-stable soft or chewy texture of the same moisture content. The coextrudate is severed into pieces to enrobe the inner cookie dough and the pieces are baked to a moisture content of at least about 6% by weight of the cookie. The outer non-adherent cookie dough, while being bakeable to a soft chewy texture, possesses sufficient cohesiveness and firmness so as to render the coextrudate formable into cookie dough pieces on a mass scale. The use of the non-adherent cookie dough to enrobe the adherent filler dough avoids sticking of the inner adherent cookie dough to oven bands and cookie dough cutting equipment.
Patent AU-5050885-A (AU)
Title: N-1h-tetrazol-5-yl-1h-indole-2-carboxamide and 2-1h- tetrazol-5-yl-1h-indole derivatives
Inventor: CONNOR DAVID T
IPC: A61K31/41
Filed: 1985-11-29
Abstract: There are disclosed compounds having the following general formula (I): 
<CHEM>
 and pharmaceutically acceptable salts thereof, wherein:
 R<1> and Q are each, independently, H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, mercapto, an alkylthio having from one to four carbon atoms, an alkylsulphinyl having from one to four carbon atoms, an alkylsulphonyl having from one to four carbon atoms, a hydroxy group, a nitro group, an amino group, substituted amino group or a halogen, R<1> being further chosen from a methylenedioxy radical attached to adjacent carbon atoms of the benzene ring; 
 R<2> is H, an alkyl having from one to twelve carbon atoms, a phenyl radical, a substituted phenyl radical or a benzyl radical;
 R<3> is H, an alkyl having from one to twelve carbon atoms, an alkoxy having from one to twelve carbon atoms, mercapto, an alkylthio having from one to four carbon atoms, a phenylthio radical, a substituted phenylthio radical, an alkylsulphinyl having from one to four carbon atoms, a phenylsulphinyl radical, a substituted phenylsulphinyl radical, an alkylsulphonyl hving from one to four carbon atoms, a phenylsolphonyl radical, a substituted phenylsolphonyl radical an amino group, or a substituted amino group; and
 R<4> is 
<CHEM>
 
<??>Methods of preparing the compounds, compositions comprising the compounds and the pharmaceutical use of the compounds are also disclosed.
Patent AU-5059599-A (AU)
Title: Diketoacid-derivatives as inhibitors of polymerases
Inventor: TOMEI LICIA
IPC: C07D249/18
Filed: 1999-07-27
Abstract: Diketoacids of Formula (A) are useful as inhibitors of viral polymerases. In particular hepatitis C virus RNA dependent RNA polymerase (HCV RdRp), hepatitis B virus polymerase (HBV pol) and reverse transcriptase of human immunodeficiency virus (HIV RN.) The group R may be broadly chosen and is an organic moiety which contains 2 to 24 carbon atoms and includes an optionally cyclic or heterocyclic group in which the atom directly bonded to the adjacent carbonyl in the diketoacid is part of the ring structure.
Patent AU-5061600-A (AU)
Title: Building construction
Inventor: BORG FINN
IPC: E04B2/74
Filed: 2000-06-08
Abstract: A building construction of wood is based on a framework of wooden battens which are arranged in several layers with mutually intersecting battens, and which are displaced from each other in such a manner that places at which there is through-going wood in the transverse direction do not generally arise at the intersecting areas. In corner areas between adjoining framework planes, the ends of the battens are adapted to form part of a labyrinth assembly. In places where a high filling with wooden parts in the transverse direction arises, the formation of cold conductors is, however, counteracted by the intersection of heat-insulation layers between two or more of the wooden parts.
Patent AU-5167479-A (AU)
Title: Pyromellitic diimides
Inventor: BOCHIS RICHARD J
IPC: A23K1/18
Filed: 1979-10-10
Abstract: Asymmetrically substituted pyromellitic diimides of formula: <CHEM> in which R1 and R2 are not the same and each represents hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, lower alkanoyl, benzoyl, di(lower alkyl)amino, lower alkanoylamino, benzoylamino, lower alkoxycarbonylamino or certain substituted phenyl or substituted lower alkyl radicals and each of X and Y is hydrogen, halogen or lower alkyl, are novel compounds that are obtainable by treating pyromellitic dianhydride with two appropriately substituted amines or with ammonia and one amine. The compounds can be administered to ruminant animals to increase their feed efficiency and suitable compositions for this purpose include the compounds with an inert carrier.
Patent AU-5276793-A (AU)
Title: Packing element
Inventor: RUKOVENA FRANK
IPC: F28F25/08
Filed: 1993-12-30
Abstract: Described are packing elements formed of a metal strip 1 having improved resistance to crushing even though made from thinner gauge metal than conventional elements. They can be obtained by providing attachment means that hold the ends of the ring together and resist deformation. The attachment means comprises at least one cooperating tab 2 and slot 4 pair. <IMAGE>
Patent AU-5287596-A (AU)
Title: Cancerous metastasis inhibitor
Inventor: SHIBATA JIRO
IPC: A61P35/04
Filed: 1996-04-10
Abstract: A cancerous metastasis inhibitor containing a benzoic acid derivative which is represented by general formula (I) and has a remarkably excellent cancerous metastasis inhibitory effect as the active ingredient; the use of the benzoic acid derivatives for producing the cancerous metastasis inhibitor; and a method of inhibiting cancerous metastasis by administering an effective amount of the benzoic acid derivative to mammals. In said formula (I), R1, R2, R3 and R4 may be the same or different and each represents hydrogen, hydroxy or trimethylsilyl, or alternatively R3 and R4 are bonded to each other to represent lower alkyl-substituted tetramethylene; and X represents -COCH=C(OH)-, -NHCO-or -CONH-, provided when R3 and R4 are bonded to each other to represent lower alkyl-substituted tetramethylene, X represents -COCH=C(OH)- or -CONH-.